Quarterly ResultJul 28, 2026, 04:33 PM
HCA Healthcare Q2 Revenue $20.23B, Diluted EPS $7.62; Repurchases $3.63B
AI Summary
HCA Healthcare reported Q2 2026 revenues of $20.23 billion, an 8.7% increase year-over-year, with diluted earnings per share rising 11.6% to $7.62. Net income attributable to HCA Healthcare, Inc. grew 2.8% to $1.699 billion. For the first six months of 2026, revenues reached $39.34 billion and diluted EPS was $14.77. The company repurchased $3.635 billion of common stock during the first half of the year and issued $3.000 billion in senior notes while redeeming $2.500 billion.
Key Highlights
- Q2 2026 revenues increased 8.7% year-over-year to $20.23 billion.
- Q2 2026 diluted earnings per share (EPS) rose 11.6% to $7.62.
- Net income attributable to HCA Healthcare, Inc. was $1.699 billion in Q2 2026.
- H1 2026 revenues increased 6.5% to $39.34 billion.
- H1 2026 diluted EPS was $14.77.
- Company repurchased $3.635 billion of common stock during H1 2026.
- Issued $3.000 billion in senior notes and redeemed $2.500 billion in Q2 2026.
- Medicaid revenue significantly increased due to Florida directed payment program.
Price Impact
More from HCA